Safety, Tolerability, and Pharmacokinetics of Multiple-Dose RFUS-949 in Healthy Chinese Participants

NCT07676357 · clinicaltrials.gov ↗

PHASE1

Phase

ACTIVE_NOT_RECRUITING

Status

28

Enrollment

OTHER

Sponsor class

Conditions

Acute and Chronic Pain

Interventions

DRUG: RFUS-949
DRUG: Placebo

Sponsor

The Affiliated Hospital of Qingdao University

Collaborators

[object Object]